PF 3084014 hydrobromide
Potent γ-secretase inhibitor (IC50 values are 1.2 and 6.2 nM in whole cell and cell-free assays, respectively). Reduces Aβ in brain, CSF and plasma in mice and guinea pigs.
Sold for research purposes under agreement from Pfizer Inc.
|Storage||Desiccate at RT|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
|water||6.51||10 with gentle warming|
Preparing Stock Solutions
The following data is based on the product molecular weight 651.47. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.53 mL||7.67 mL||15.35 mL|
|5 mM||0.31 mL||1.53 mL||3.07 mL|
|10 mM||0.15 mL||0.77 mL||1.53 mL|
|50 mM||0.03 mL||0.15 mL||0.31 mL|
References are publications that support the biological activity of the product.
Lanz et al (2010) Pharmacodynamics and pharmacokinetics of the gamma-secretase inhibitor PF-3084014. J.Pharmacol.Exp.Ther. 334 269 PMID: 20363853
If you know of a relevant reference for PF 3084014 hydrobromide, please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: PF 3084014 hydrobromide, PF 3084014 hydrobromide supplier, PF3084014, hydrobromide, gamma, secretase, inhibitors, inhibits, γ, Abeta, amyloid, β, Gamma-Secretase, Amyloid, Beta, Peptides, 5751, Tocris Bioscience
Citations for PF 3084014 hydrobromide
Citations are publications that use Tocris products.
Currently there are no citations for PF 3084014 hydrobromide. Do you know of a great paper that uses PF 3084014 hydrobromide from Tocris? Please let us know.
Reviews for PF 3084014 hydrobromide
There are currently no reviews for this product. Be the first to review PF 3084014 hydrobromide and earn rewards!
Have you used PF 3084014 hydrobromide?
Submit a review and receive an Amazon gift card.
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Literature in this Area
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* or download your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
Alzheimer's disease (AD) is a degenerative brain disease and the most common cause of dementia, affecting approximately 47 million people worldwide. Updated in 2015, this poster summarizes the structural and functional changes observed in the progression of this neurodegenerative disease, as well as classic AD drug targets.